tiprankstipranks
Navidea Biopharmaceuticals (NAVB)
OTHER OTC:NAVB

Navidea (NAVB) Stock Price & Analysis

307 Followers

NAVB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.02 - $0.15
Previous Close$0.06
Volume750.00
Average Volume (3M)63.53K
Market Cap
$100.08K
Enterprise Value-$3.46M
Total Cash (Recent Filing)$3.86M
Total Debt (Recent Filing)$10.70K
Price to Earnings (P/E)
Beta-47.12
Aug 07, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding99,830,635
10 Day Avg. Volume2,271,982
30 Day Avg. Volume63,534
Standard Deviation0.35
R-Squared0.05
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-1.86
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.30
P/FCF Ratio0.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-5.67K
Enterprise Value/Gross Profit20.33
Enterprise Value/Ebitda0.77
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

6.09%0.87%0.01%93.03%
0.01% Other Institutional Investors
93.03% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

NAVB FAQ

What was Navidea Biopharmaceuticals’s price range in the past 12 months?
Navidea Biopharmaceuticals lowest stock price was $0.02 and its highest was $0.14 in the past 12 months.
    What is Navidea Biopharmaceuticals’s market cap?
    Currently, no data Available
    When is Navidea Biopharmaceuticals’s upcoming earnings report date?
    Navidea Biopharmaceuticals’s upcoming earnings report date is Aug 07, 2024 which is in 25 days.
      How were Navidea Biopharmaceuticals’s earnings last quarter?
      Currently, no data Available
      Is Navidea Biopharmaceuticals overvalued?
      According to Wall Street analysts Navidea Biopharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Navidea Biopharmaceuticals pay dividends?
        Navidea Biopharmaceuticals does not currently pay dividends.
        What is Navidea Biopharmaceuticals’s EPS estimate?
        Navidea Biopharmaceuticals’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Navidea Biopharmaceuticals have?
        Navidea Biopharmaceuticals has 100,084,390 shares outstanding.
          What happened to Navidea Biopharmaceuticals’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Navidea Biopharmaceuticals?
          Currently, no hedge funds are holding shares in NAVB
          ---

          Navidea Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Company Description

          Navidea Biopharmaceuticals

          Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.
          ---

          NAVB Earnings Call

          Q4 2023
          0:00 / 0:00
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Aptose Biosciences
          Brainstorm Cell Therapeutics
          Bio-Path Holdings
          Cidara Therapeutics
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis